1. Born, S. L., Caudill, D., Fliter, K. L., and Purdon, M. P., Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab. Dispos., 30, 483–487 (2002).
2. Brady, J. F., Xiao, F., Wang, M. H., Li, Y., Ning, S. M., Gapac, J. M., and Yang, C. S., Effects of disulfiram on hepatic P450 IIE1, other microsomal enzymes and hepatotoxicity in rats. Toxicol. Appl. Pharmacol., 108, 366–373 (1991).
3. Chang, H., Chu, X. Y., Zou, J., and Chang, T. H., Effects of peucedanum praeruptorum dunn, a traditional Chinese medicine on acute myocardial infarction in open chest anesthetized cats. J. China Med. Univ., 29, 84–87 (2000).
4. Chang, T. H., Liu, X. Y., Zhang, X. H., and Wang, H. L., Effects of dl-praeruptorin A on interleukin-6 level and Fas, bax, bcl-2 protein expression in ischemia-reperfusion myocardium. Acta Pharmacol. Sin., 23, 769–774 (2002).
5. Chung, H. J., Choi, Y. H., Kim, S. H., and Lee, M. G., Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats. J. Pharm. Pharmacol., 58, 449–457 (2006).